Cargando…

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern

Detalles Bibliográficos
Autores principales:	Yue, Lei, Zhou, Jian, Zhou, Yanan, Yang, Xiaolei, Xie, Tianhong, Yang, Mengli, Zhao, Hongling, Zhao, Yuan, Yang, Ting, Li, Hua, Xiang, Hong, Wang, Jie, Lu, Shuaiyao, Liu, Hongqi, Zhao, Hong, Wei, Xingchen, Zhang, Yuhao, Xie, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604510/ https://www.ncbi.nlm.nih.gov/pubmed/34666622 http://dx.doi.org/10.1080/22221751.2021.1996210

Ejemplares similares

Susceptibility of tree shrew to SARS-CoV-2 infection
por: Zhao, Yuan, et al.
Publicado: (2020)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern
por: Xie, Tianhong, et al.
Publicado: (2022)

Animal models for SARS‐CoV‐2 infection and pathology
por: Bi, Zhenfei, et al.
Publicado: (2021)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation
por: Lu, Shuaiyao, et al.
Publicado: (2020)

The Gastrointestinal Tract Is an Alternative Route for SARS-CoV-2 Infection in a Nonhuman Primate Model
por: Jiao, Li, et al.
Publicado: (2021)

Neurological complications and infection mechanism of SARS-CoV-2
por: Wan, Dandan, et al.
Publicado: (2021)

Characteristic analysis of Omicron‐included SARS‐CoV‐2 variants of concern
por: Yang, Hao, et al.
Publicado: (2022)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
por: He, Xiangchuan, et al.
Publicado: (2021)

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
por: Li, Ruofan, et al.
Publicado: (2022)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021)

Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques
por: Chen, Hongbo, et al.
Publicado: (2021)

The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys
por: Jiao, Li, et al.
Publicado: (2021)

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
por: Xu, Jiabao, et al.
Publicado: (2020)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
por: Hong, Weiqi, et al.
Publicado: (2021)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020)

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
por: Li, Huan, et al.
Publicado: (2020)

Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice
por: Huang, Qing, et al.
Publicado: (2023)

Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
por: Liu, Yang, et al.
Publicado: (2021)

Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants
por: Zhao, Xin, et al.
Publicado: (2021)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Endomembrane remodeling in SARS-CoV-2 infection
por: Chen, Di, et al.
Publicado: (2022)

The Epitope Study on the SARS-CoV Nucleocapsid Protein
por: Li, Shuting, et al.
Publicado: (2003)

A comprehensive survey of bat sarbecoviruses across China in relation to the origins of SARS-CoV and SARS-CoV-2
por: Wu, Zhiqiang, et al.
Publicado: (2022)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
por: Abdelghany, T.M., et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Biochemical characterization of SARS-CoV-2 nucleocapsid protein
por: Zeng, Weihong, et al.
Publicado: (2020)

Potential infectious risk from the pets carrying SARS-CoV-2
por: Wang, Haizhou, et al.
Publicado: (2020)

H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection
por: Zhou, Nan, et al.
Publicado: (2021)

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
por: Souza, William M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dsa41h1h3ge08rbc8jif26h6dh